91 related articles for article (PubMed ID: 10689717)
1. A longitudinal study of cardiac function in children with cancer over 40 months.
Li CK; Sung RY; Kwok KL; Leung TF; Shing MM; Chik KW; Yu CW; Yam MC; Yuen PM
Pediatr Hematol Oncol; 2000; 17(1):77-83. PubMed ID: 10689717
[TBL] [Abstract][Full Text] [Related]
2. Dynamic stress echocardiography in asymptomatic patients who received chemotherapy in childhood because of a malignant disease.
Elbl L; Hrstkova H; Chaloupka V; Michalek J
Kardiol Pol; 2003 Mar; 58(3):190-6. PubMed ID: 14513093
[TBL] [Abstract][Full Text] [Related]
3. Exercise echocardiography in asymptomatic survivors of childhood cancer treated with anthracyclines: a prospective follow-up study.
Sieswerda E; Kremer LC; Vidmar S; De Bruin ML; Smibert E; Sjöberg G; Cheung MM; Weintraub RG
Pediatr Blood Cancer; 2010 Apr; 54(4):579-84. PubMed ID: 20014238
[TBL] [Abstract][Full Text] [Related]
4. B-type natriuretic peptide as a marker for cardiac dysfunction in anthracycline-treated children.
Aggarwal S; Pettersen MD; Bhambhani K; Gurczynski J; Thomas R; L'Ecuyer T
Pediatr Blood Cancer; 2007 Nov; 49(6):812-6. PubMed ID: 17171687
[TBL] [Abstract][Full Text] [Related]
5. [Dynamic stress echocardiography in asymptomatic patients treated for malignant diseases in childhood].
Elbl L; Hrstková H; Chaloupka V; Novotný J
Vnitr Lek; 2003 Apr; 49(4):273-9. PubMed ID: 12793049
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of late cardiac toxicity of anthracycline in childhood].
Butera G; Piciacchia D; Chessa M; Condoluci C; Tornesello A; Delogu AB; Mastrangelo S; Cipriani A
Minerva Pediatr; 1998 Apr; 50(4):111-9. PubMed ID: 9808963
[TBL] [Abstract][Full Text] [Related]
7. Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia.
Rathe M; Carlsen NL; Oxhøj H
Pediatr Blood Cancer; 2007 Jun; 48(7):663-7. PubMed ID: 17405151
[TBL] [Abstract][Full Text] [Related]
8. [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
Elbl L; Vásová I; Krejcí M; Navrátil M; Tomásková I; Jedlicka F; Chaloupka V; Mayer J; Vorlícek J
Vnitr Lek; 2006 Mar; 52(3):221-31. PubMed ID: 16722153
[TBL] [Abstract][Full Text] [Related]
9. Cardiotoxicity of anthracycline in young breast cancer female patients: the possibility of detection of early cardiotoxicity by TDI.
Nagy AC; Tolnay E; Nagykálnai T; Forster T
Neoplasma; 2006; 53(6):511-7. PubMed ID: 17167721
[TBL] [Abstract][Full Text] [Related]
10. [Anthracycline-induced cardiotoxicity: cardiac MRI after treatment for childhood cancer].
Oberholzer K; Kunz RP; Dittrich M; Thelen M
Rofo; 2004 Sep; 176(9):1245-50. PubMed ID: 15346258
[TBL] [Abstract][Full Text] [Related]
11. A stress echocardiography study of cardiac function during progressive exercise in pediatric oncology patients treated with anthracyclines.
De Souza AM; Potts JE; Potts MT; De Souza ES; Rowland TW; Pritchard SL; Sandor GG
Pediatr Blood Cancer; 2007 Jul; 49(1):56-64. PubMed ID: 17226848
[TBL] [Abstract][Full Text] [Related]
12. Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines.
Mavinkurve-Groothuis AM; Groot-Loonen J; Bellersen L; Pourier MS; Feuth T; Bökkerink JP; Hoogerbrugge PM; Kapusta L
Pediatr Blood Cancer; 2009 May; 52(5):631-6. PubMed ID: 19127569
[TBL] [Abstract][Full Text] [Related]
13. Design and baseline characteristics for the ACE Inhibitor After Anthracycline (AAA) study of cardiac dysfunction in long-term pediatric cancer survivors.
Silber JH; Cnaan A; Clark BJ; Paridon SM; Chin AJ; Rychik J; Hogarty AN; Cohen MI; Barber G; Rutkowsky M; Kimball TR; Delaat C; Steinherz LJ; Zhao H; Tartaglione MR
Am Heart J; 2001 Oct; 142(4):577-85. PubMed ID: 11579345
[TBL] [Abstract][Full Text] [Related]
14. [Subacute cardiotoxicity caused by anthracycline therapy in children: can dexrazoxane prevent this effect?].
Erlaky H; Tóth K; Szabolcs J; Horváth E; Kemény V; Müller J; Csóka M; Jókúti L; Erdélyi D; Kovács G
Magy Onkol; 2006; 50(1):25-32. PubMed ID: 16617380
[TBL] [Abstract][Full Text] [Related]
15. Presence of prolonged dispersion of qt intervals in late survivors of childhood anthracycline therapy.
Gupta M; Thaler HT; Friedman D; Steinherz L
Pediatr Hematol Oncol; 2002 Dec; 19(8):533-42. PubMed ID: 12487828
[TBL] [Abstract][Full Text] [Related]
16. Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines.
Silber JH; Cnaan A; Clark BJ; Paridon SM; Chin AJ; Rychik J; Hogarty AN; Cohen MI; Barber G; Rutkowski M; Kimball TR; Delaat C; Steinherz LJ; Zhao H
J Clin Oncol; 2004 Mar; 22(5):820-8. PubMed ID: 14990637
[TBL] [Abstract][Full Text] [Related]
17. Assessment of anthracycline-induced cardiotoxicity with electrocardiography.
Horacek JM; Jakl M; Horackova J; Pudil R; Jebavy L; Maly J
Exp Oncol; 2009 Jun; 31(2):115-7. PubMed ID: 19550402
[TBL] [Abstract][Full Text] [Related]
18. The evaluation of left ventricular function in childhood cancer survivors by pharmacological stress echocardiography.
Elbl L; Hrstkova H; Chaloupka V; Novotny J; Michalek J
Neoplasma; 2003; 50(3):191-7. PubMed ID: 12937852
[TBL] [Abstract][Full Text] [Related]
19. Acute cardiac functional and morphological changes after Anthracycline infusions in children.
Ganame J; Claus P; Eyskens B; Uyttebroeck A; Renard M; D'hooge J; Gewillig M; Bijnens B; Sutherland GR; Mertens L
Am J Cardiol; 2007 Apr; 99(7):974-7. PubMed ID: 17398195
[TBL] [Abstract][Full Text] [Related]
20. Anthracycline induced cardiac toxicity in pediatric Ewing sarcoma: a longitudinal study.
Brown TR; Vijarnsorn C; Potts J; Milner R; Sandor GG; Fryer C
Pediatr Blood Cancer; 2013 May; 60(5):842-8. PubMed ID: 23382019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
